Search for: "Stephen Gottlieb"
Results 21 - 40
of 145
Sort by Relevance
|
Sort by Date
24 Dec 2021, 6:26 am
, Proxy advisors, Proxy voting, SEC, SEC rulemaking, Securities litigation, Securities regulation, Shareholder voting ESG and 2021 Year-End Financial Reporting Season Posted by Maria Castañón Moats and Stephen G. [read post]
19 Nov 2021, 5:57 am
Derivative Litigation Concerning Foreign Private Issuers Posted by Stephen Blake, Adam Goldberg, and Bo Bryan Jin, Simpson Thacher & Bartlett LLP, on Sunday, November 14, 2021 Tags: China, Derivative suits, Foreign firms, Foreign issuers, International governance, Minority shareholders, New York, Securities litigation, Settlements, Shareholder suits FSOC Issues Report Declaring Climate Change as Emerging Threat to U.S. [read post]
12 Nov 2021, 6:07 am
Census Bureau), on Tuesday, November 9, 2021 Tags: Compensation disclosure, Compensation ratios, Firm performance, Incentives, Management, Pay for performance New DOL Proposal on ESG Investing and Fiduciary Exercise of Shareholder Rights Posted by Mary Alcock, Michael Albano, and Francesca Crooks, Cleary Gottlieb Steen & Hamilton LLP, on Tuesday, November 9, 2021 Tags: DOL, ERISA, ESG, Fiduciary rule, Institutional… [read post]
10 Oct 2021, 9:05 pm
Stephen Hahn, who took over as Commissioner on Dec. 17, 2019, is a cancer doctor. [read post]
23 Apr 2021, 5:50 am
Interest in SPACs is Booming…and So is the Risk of Litigation Posted by Stephen Fraidin, Gregory P. [read post]
16 Apr 2021, 5:51 am
Posted by Mark Roe (Harvard Law School) and Federico Cenzi Venezze (Cleary Gottlieb Steen & Hamilton LLP), on Tuesday, April 13, 2021 Tags: Capital formation, Capital structure, Institutional Investors, Investor horizons, Long-Term value, Shareholder activism, Short-termism How Audit Committees Can Prepare for 2021 Q1 Reporting Posted by Stephen Klemash and Jennifer Lee, EY, on Tuesday, April 13, 2021 … [read post]
26 Mar 2021, 6:09 am
Larcker (Stanford University), Brian Tayan (Stanford University), and Stephen A. [read post]
5 Feb 2021, 5:30 am
Written by Dr Ben Köhler, MPI Hamburg Last week, following severe criticisms of its procurement strategy and a dispute with AstraZeneca over the delays in delivery of the vaccine, the EU Commission has published the Advance Purchase Agreement for the Production, Purchase and Supply of a Covid-19 Vaccine in the European Union (APA) it had concluded with AstraZeneca in August 2020. [read post]
22 Jan 2021, 5:54 am
Corrigan (Notre Dame Law School), on Tuesday, January 19, 2021 Tags: Capital formation, Capital markets, Equity offerings, IPOs, Market reaction, Regulation M, Securities regulation, Underwriting How Boards Can Promote a New Leadership Model for Companies Posted by Seymour Burchman and Blair Jones, Semler Brossy, on Tuesday, January 19, 2021 Tags: Boards of Directors, Corporate purpose, ESG, Executive Compensation, Human… [read post]
20 Jan 2021, 6:02 am
Posted by Nicolas Grabar, Nina Bell, and Stephen Janda, Cleary Gottlieb Steen & Hamilton LLP, on Wednesday, January 20, 2021 Editor's Note: Nicolas Grabar is partner and Nina Bell and Stephen Janda are associates at Cleary Gottlieb Steen & Hamilton LLP. [read post]
15 Jan 2021, 5:58 am
Berman, and Stephen B. [read post]
13 Nov 2020, 6:11 am
Milano, Fortuna Advisors, on Monday, November 9, 2020 Tags: Boards of Directors, Capital markets, Corporate purpose, Corporate Social Responsibility, COVID-19, Engagement, ESG, Firm performance, Firm valuation, Management, Manager characteristics, Shareholder value, Stakeholders, Surveys SEC Extends Its Focus on MNPI Clearance Procedures Posted by Stephen Cutler, Brad Goldberg and Nicholas Goldin, Simpson Thacher… [read post]
14 Oct 2020, 4:33 am
Stephen Ostroff, a former acting commissioner of the F.D.A., who serves as one of the chairs (with Dr. [read post]
9 Oct 2020, 6:05 am
McDonald, Cleary Gottlieb Steen & Hamilton LLP, on Friday, October 2, 2020 Tags: Boards of Directors, Controlling shareholders, Corwin, Delaware cases, Delaware law, Fiduciary duties, Merger litigation, Mergers & acquisitions SEC Amends Disclosure Requirements for Business Sections, Legal Proceedings and Risk Factors Posted by Mark S. [read post]
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm
This created a Catch-22, as former FDA Commissioner Scott Gottlieb put it; rapid development of COVID-19 tests was needed in the emergency, but the emergency-based EUA requirement slowed them down. [read post]
4 Aug 2020, 10:51 am
Gottlieb, Unfit for Democracy: The Roberts Court and the Breakdown of American Politics 173-77 (NYU Press, 2016). [read post]
17 Jul 2020, 5:51 am
Forman, Cornerstone Research, on Sunday, July 12, 2020 Tags: Accounting, Audits, Financial reporting, Foreign firms, PCAOB, Restatements, Sarbanes–Oxley Act, SEC, SEC enforcement, Securities enforcement, Securities fraud COVID-19: Navigating Core Audit Committee Responsibilities Posted by Paula Loop, Paul DeNicola, and Stephen G. [read post]
28 Jun 2020, 8:14 pm
[ii] Stephen Gottlieb, Unfit for Democracy: The Roberts Court and the Breakdown of American Politics 189-208 (2016). [read post]
26 Jun 2020, 6:01 am
McDonald, Cleary Gottlieb Steen & Hamilton LLP, on Monday, June 22, 2020 Tags: Boards of Directors, Conflicts of interest, Delaware cases, Delaware law, Financial advisers, Going private, Merger litigation, Mergers & acquisitions The Rise of Standardized ESG Disclosure Frameworks in the United States Posted by Catherine M. [read post]
4 May 2020, 10:09 am
So far, 12 antibody tests have been authorized by the FDA for emergency use, and more than 250 tests are currently the subject of a pre-EUA or EUA review, FDA Commissioner Stephen Hahn told reporters Monday. [read post]
